Bibliografia UJ CM

1/7
Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Krish Patel, Toby A. Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S. Tam, Nirav N. Shah, Catherine C. Coombs, Chaitra S. Ujjani, Bita Fakhri, Chan Y. Cheah, Manish R. Patel, Alvaro J. Alencar, Jonathon B. Cohen, James N. Gerson, Ian W. Flinn, Shuo Ma, Deepa Jagadeesh, Joanna M. Rhodes, Francisco Hernandez-Ilizalitur, Pier L. Zinzani, John F. Seymour, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Amy S. Ruppert, Denise Wang, Donald E. Tsai, William G. Wierda, Wojciech Jurczak.
Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia
New England Journal of Medicine
2023 : Vol. 389, nr 1, s. 33-44, il., bibliogr. 32 poz., abstr.
Autor korespondencyjny: Jennifer A. Woyach
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 158.500
Adres url:
Streszczenie w PubMed:
2/7
Michael L. Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S. Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S. Fenske, John F. Seymour, Andrew D. Zelenetz, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato, Nirav N. Shah.
Pirtobrutinib in covalent BTK-inhibitor pre-treated mantle cell lymphoma
Journal of Clinical Oncology
2023, il., bibliogr. 35 poz., sum.
Autor korespondencyjny: Michael L. Wang
Online First 2023-05-16
p-ISSN: 0732-183X
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
3/7
John C. Byrd, Peter Hillmen, Paolo Ghia, Arnon P. Kater, Asher Chanan-Khan, Richard R. Furman, Susan O'Brien, Mustafa Nuri Yenerel, Arpad Illés, Neil Kay, Jose A. Garcia-Marco, Anthony Mato, Javier Pinilla-Ibarz, John F. Seymour, Stephane Lepretre, Stephan Stilgenbauer, Tadeusz Robak, Wayne Rothbaum, Raquel Izumi, Ahmed Hamdy, Priti Patel, Kara Higgins, Sophia Sohoni, Wojciech Jurczak.
Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia : results of the first randomized phase III trial.
Journal of Clinical Oncology
2021 : Vol. 39, nr 31, s. 3441-3452, il., bibliogr. 37 poz.
Autor korespondencyjny: John C. Byrd.
Open Access Creative Commons Attribution License CC-BY-NC ND 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
4/7
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Peter Hillmen, John F. Seymour, Steven Coutre, Wojciech Jurczak, Stephen P. Mulligan, Anna Schuh, Sarit Assouline, Clemens-Martin Wendtner, Andrew W. Roberts, Matthew S. Davids, Johannes Bloehdorn, Talha Munir, Sebastian Bottcher, Lang Zhou, Ahmed Hamed Salem, Monali Desai, Brenda Chyla, Jennifer Arzt, Su Young Kim, Maria Verdugo, Gary Gordon, Michael Hallek, William G. Wierda.
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial .
Journal of Clinical Oncology
2018 : Vol. 36, nr 9, s. 1973-1980
Autor korespondencyjny: Stephan Stilgenbauer.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
5/7
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Steven Coutre, John F. Seymour, Talha Munir, Soham D. Puvvada, Clemens-Martin Wendtner, Andrew W. Roberts, Wojciech Jurczak, Stephen P. Mulligan, Sebastian Böttcher, Mehrdad Mobasher, Ming Zhu, Monali Desai, Brenda Chyla, Maria Verdugo, Sari Heitner Enschede, Elisa Cerri, Rod Humerickhouse, Gary Gordon, Michael Hallek, William G. Wierda.
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Lancet. Oncology
2016 : Vol. 17, nr 6, s. 768-778, il., bibliogr. 30 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
6/7
Susan O'Brien, Joseph O. Moore, Thomas E. Boyd, Loree M. Larratt, Aleksander Skotnicki, Benjamin Koziner, Asher A. Chanan-Khan, John F. Seymour, R. Gregory Bociek, Steve Pavletic, Kanti R. Rai.
Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of Clinical Oncology
2007 : Vol. 25, nr 9, s. 1114-1120, il., bibliogr., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 15.484
7/7
Susan Branford, Zbigniew Rudzki, Ian Parkinson, Andrew Grigg, Kerry Taylor, John F. Seymour, Simon Durrant, Peter Browett, Anthony P. Schwarer, Chris Arthur, John Catalano, Michael F. Leahy, Robin Filshie, Kenneth Bradstock, Richard Hermann, David Joske, Kevin Lynch, Tim Hughes.
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Blood
2004 : Vol. 103, nr 9, s. 2926-2932, il., bibliogr. 38 poz.
AZ
ORG
AIF
IF: 9.782
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ